secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2026-11-09T21:16:37+00:00
Accession:  0001193125-26-453635
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Stryker expands board to 12, elects Quest Diagnostics CEO Jim Davis effective Jan 1, 2027
--------------------------------------------------------------------------------

- Board increased authorized directors from 11 to 12 and elected James E. Davis to fill the vacancy; term begins January 1, 2027.
- Davis has been CEO and President of Quest Diagnostics since November 2022 and Chairman of the Quest board since April 2023.
- Prior roles: CEO of InSightec, two decades at GE including five years leading GE's MRI business, and earlier McKinsey client work.
- Not appointed to any board committee at this time; pay will match other non-employee directors per the 2026 proxy statement.
- CEO Kevin Lobo cited Davis's healthcare experience and medical-technology understanding as the rationale for the nomination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000119312526453635/0001193125-26-453635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000119312526453635/d101928d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-453635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer